Document is current
Any future updates will be listed below
-
Authors
Corominas, Jordi
Klein, Marieke https://orcid.org/0000-0001-8784-5679
Zayats, Tetyana
Rivero, Olga https://orcid.org/0000-0002-2664-4053
Ziegler, Georg C.
Pauper, Marc
Neveling, Kornelia
Poelmans, Geert
Jansch, Charline
Svirin, Evgeniy
Geissler, Julia
Weber, Heike https://orcid.org/0000-0002-9421-1292
Reif, Andreas https://orcid.org/0000-0002-0992-634X
Arias Vasquez, Alejandro
Galesloot, Tessel E.
Kiemeney, Lambertus A. L. M.
Buitelaar, Jan K.
Ramos-Quiroga, Josep-Antoni
Cormand, Bru
Ribasés, Marta https://orcid.org/0000-0003-1039-1116
Hveem, Kristian
Gabrielsen, Maiken Elvestad
Hoffmann, Per
Cichon, Sven
Haavik, Jan
Johansson, Stefan
Jacob, Christian P.
Romanos, Marcel
Franke, Barbara https://orcid.org/0000-0003-4375-6572
Lesch, Klaus-Peter
- License Information
-
More Information
Article History
Received: 8 June 2017
Revised: 1 May 2018
Accepted: 18 June 2018
First Online: 16 August 2018
Compliance with ethical standards
:
: BF received educational speaking fees from Merz and Shire. KPL served as a speaker for Eli Lilly and received research support from Medice, as did AR, all outside the submitted work. JH received speaker fees from Eli Lilly, HB Pharma, and Shire. In the past 3 years, JKB has been a consultant to/member of advisory board of/and/or speaker for Janssen Cilag BV, Eli Lilly, Lundbeck, Shire, Roche, Medice, Novartis, and Servier. He has received research support from Roche and Vifor. He is not an employee of any of these companies, and not a stock shareholder of any of these companies. He has no other financial or material support, including expert testimony, patents, royalties. All other authors report no biomedical financial interests or potential conflicts of interest.
